Navigation Links
Nile Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Date:8/27/2008

SAN FRANCISCO, Aug. 27 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc., (Nasdaq: NLTX), today announced that Peter Strumph, Chief Executive Officer of Nile, will present at the NewsMakers in the Biotech Industry conference on Thursday, September 4, at 1:30 p.m. EDT at the Millennium Broadway Hotel in New York City. Mr. Strumph will provide a company overview and update on the status of Nile's current clinical development programs.

The presentation will be webcast live and can be accessed by visiting the Investor Relations section of Nile's website at http://www.nilethera.com. The webcast will be archived for 90 days.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical need. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure; 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide donating properties; and CU-NP, a novel rationally designed natriuretic peptide. A key component of the company's strategy is to acquire the global rights to additional compounds to expand its portfolio. More information on Nile can be found at http://www.nilethera.com.

Contact:

Daron Evans

Chief Financial Officer

Nile Therapeutics, Inc.

415-875-7880

info@nilethera.com

This press release contains forward-looking statements within the meani
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
2. Cell Therapeutics, Inc. Announces Reverse Stock Split
3. Pixel Bridge Works With Anika Therapeutics to Launch New Website
4. Duska Therapeutics to Present at Noble Financial Equity M.A.D. MAX Conference on Tuesday, August 19th at 1:30 p.m. PDT
5. Arno Therapeutics Announces Second Quarter 2008 Financial Results
6. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
7. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
10. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
11. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Patients who were treated with a statin ... were significantly more likely to survive than those who ... JAMA Neurology . This study was conducted by ... of cholesterol-lowering statins can improve survival in victims of ... or obstruction of a blood vessel that blocks blood ...
(Date:9/22/2014)... NEW YORK and SANTA CLARA, ... Health Corp. (NASDAQ: WBMD ), the leading ... a new WebMD/Medscape survey that provide novel ... role in aiding diagnosis and care.  Dr. Eric ... genomics and digital medicine, who serves as both Editor-in-Chief ...
(Date:9/22/2014)... components developed by researchers at the USC Viterbi ... build a 3-D microfluidic system quickly and cheaply ... , Microfluidic systems are used in many ... manipulate small volumes of fluids for use in ... detection, clinical diagnostic testing, and synthetic chemistry. Traditionally, ...
(Date:9/22/2014)... tumor cells (CTCs) in a mouse model of pancreatic ... groups of CTCs, including significant differences from the primary ... metastases. In their study reported in the Sept. ... the Massachusetts General Hospital (MGH) Cancer Center identified several ... that may prove to be targets for improved treatment ...
Breaking Biology Technology:Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 3Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 5Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3
... Patent 7,507,704 issued on 03/24/09 to NexGen Biomedical, ... an improved method of treating lung, brain, pancreatic, breast ... known as HER1 overexpression (also called EGFR or c-ErbB-1). ... concurrent HER1 blocker / S-Phase cytotoxic protocols achieve only ...
... -- WuXi AppTec (NYSE: WX ), a ... with operations in China and the United States, today,announced ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ... joined WuXi AppTec as Vice President of Toxicology and,Head ...
... Release Hospitals Highlights Early Clinical Benefits and Patient ... MASI ), the inventor of Pulse ... announced today that it has initiated the full ... hemoglobin (SpHb(TM)) monitoring technology. As the first noninvasive ...
Cached Biology Technology:Patent for Making Combination Chemotherapy Work Better 2WuXi AppTec Welcomes Three Senior Professionals 2Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 2Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 3Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 4Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 5Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 6
(Date:9/23/2014)... Although the immediate welfare consequences of removing infant chimpanzees ... about the long-term impacts of this type of early ... Park Zoon observed 60 chimpanzees and concluded that those ... and raised by humans as pets or performers are ... , The multi-institutional research project, published today in the ...
(Date:9/22/2014)... the University of Chicago have shown that after a ... a handful of pathogenic microbe species remain behind in ... discovered that some can become deadly when provoked by ... , The findings, published in mBio , the ... may lead to better monitoring and treatment of ICU ...
(Date:9/22/2014)... Many native species have vanished from tropical islands ... scientists have discovered how fossils can be used ... lies in organic materials found in fossil bones, ... according to a new study available online and ... of Herpetology . Pre-human island ecosystems provide vital ...
Breaking Biology News(10 mins):Chimpanzees raised as pets or performers suffer long-term effects on their behavior 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3Answer to restoring lost island biodiversity found in fossils 2
... Hopkins neuroscientists has worked out how some newly discovered ... with the brain. The report appears online this week ... are a small number of nerve cells in the ... in the retinarods and conesmelanopsin-containing cells are not used ...
... While examining patterns of DNA modification in lung cancer, ... is a surprising new mechanism. They say that "silencing" of ... impairment in genome-wide changes in cells, contributing to cancer development ... Cancer Research , a journal of the American Association ...
... will be one step closer to better drought-tolerant soybean ... database of all proteins and metabolites in soybeans. Once ... in proteins and metabolites in soybeans grown under drought ... the recently released soybean genome, scientists will have a ...
Cached Biology News:Bright lights, not-so-big pupils 2Bright lights, not-so-big pupils 3In lung cancer, silencing one crucial gene disrupts normal functioning of genome 2In lung cancer, silencing one crucial gene disrupts normal functioning of genome 3Soybean database will help breeders engineer better-performing plants 2
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products: